Новые биологически активные соединения в ряду производных 3-(индол-1-ил)-, З-(N-аминоарил)- и 3-(S-тиоарил)малеимида
Аннотация
Об авторах
С. А. ЛакатошРоссия
А. С. Тренин
Россия
А. Ю. Симонов
Россия
С. Н. Лавренов
Россия
О. П. Бычкова
Россия
Е. А. Цвигун
Россия
Список литературы
1. Trenin A.S. Metodologija poiska novykh antibiotikov: sostojanie i perspektivy. Antibiotiki i khimioter 2015; 60: 7-8: 34-46
2. . Drug discovery: practices, processes, and perspectives / Ed. by Jie Jack Li, E.J. Corey. ISBN 978-0-470-94235-2, John Wiley & Sons, Inc., 570 p
3. Cohen P. Protein kinases - the major drug targets of the twenty-first century. Nat Rev Drug Discov 2002; 1: 4: 309-315.
4. Shugar D. Viral and host-cell protein kinases: enticing antiviral targets and relevance of nucleoside, and viral thymidine, kinases. Pharmacol Ther 1999; 82: 2-3: 315-335.
5. Pindur U, Kim Y.-S, Mehrabani F. Advances in indolo[2,3-a]carbazole chemistry: design and synthesis of protein kinase C and topoisomerase I inhibitors. Curr Med Chem 1999; 6: 1: 29-69.
6. Mahboobi S., Eichhorn E., Popp A. et al. 3-Bromo-4-(1H-3-indolyl)-2,5-dihydro-1H-2,5-pyrroledione derivatives as new lead compounds for antibacterially active substances. Eur J Med Chem 2006; 41: 2: 176-191.
7. Moreau P., Anizon F., Sancelme M. et al. Syntheses and biological evaluation of indolocarbazoles, analogues of rebeccamycin, modified at the imide heterocycle. J Med Chem 1998; 41: 10: 1631-1640.
8. Omura S., Iwai Y, Nakayawa A. et al. A new alkaloid AM-2282 OF Streptomyces origin. Taxonomy, fermentation, isolation and preliminary characterization. J Antibiot (Tokyo), 1977; 30: 4: 275-282.
9. Rüegg U.T., Burgess G.M. Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases. Trends in Pharmacological Science 1989; 10: 6: 218-220.
10. Davies S.P., Reddy H., Caivano M., Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000; 351 (Pt 1): 95-105.
11. Danilenko V.N., Osolodkin D.I., Lakatosh S.A., Preobrazhenskaya M.N., Shtil A.A. Bacterial Eukaryotic Type Serine-Threonine Protein Kinases: From Structural Biology to Targeted Anti-Infective Drug. Curr Top Med Chem 2011; 11: 1352-1369.
12. Santos J.L., Shiozaki K. Fungal Histidine Kinases. Science's STKE 2001; 2001: Issue 98: pp. re1.
13. Simonov A.Y., Lakatosh S.A., Printsevskaya S.S. et al. Search for Inhibitors of Bacterial and Human Protein Kinases among Derivatives of Diazepines[1,4] Annelated with Maleimide and Indole Cycles. J Med Chem 2008; 51: 24: 7731-7736.
14. Simonov A.Yu., Lakatosh S.A., Luzikov Yu.N. et al. Synthesis of 4-substi-tuted 3-[3-(dialkylaminomethyl)indol-1-yl]maleimides and study of their ability to inhibit protein kinase Ca, prevent development of multiple drug resistance of tumor cells and cytotoxicity. Russian Chemical Bulletin, International Edition. 2008; 57: 9: 2011-2020.
15. Simonov A.Yu., Lakatosh S.A., Luzikov Yu.N., Reznikova M.I., Preobrazhenskaya M.N. Nucleophilic substitution and cyclization reactions involving quaternized 3dimethylaminomethyl derivatives of 3,4bis(indol1yl)maleimide and 3-(indol-1-yl)-4-(indolin-1-yl)maleimide. Russian Chemical Bulletin, International Edition. 2010; 59: 7: 1442-1450.
16. Lakatosh S.A., Luzikov Y.N., Preobrazhenskaya M.N. Synthesis of 6H-pyrrolo[3',4':2,3][1,4]diazepino[6,7,1-hi]indole-8,10(7H,9H)-diones using 3-bromo-4-(indol-1-yl)maleimide scaffold. Organ Biomolec Chem 2003; 1: 826-833.
17. Simonov A.Y., Lakatosh S.A., Luzikov Yu.N. et al. Macrolactones built from the bis-3,4(indol-1-yl)maleimide scaffold Tetrahedron 2014; 70: 625-630.
18. Lakatosh S.A., Bykov E.E., Preobrazhenskaya M.N. Synthesis of 2-het-aryl-3-(indol-1-yl)-and -(3-pyrrol-1-yl)maleimides and study of their conversions under the action of protic acids. Chem Heterocyclic Comp 2011; 46: 1224-1232.
19. Lavrenov S.N., Luzikov Y.N., Bykov E.E. et al. Synthesis and cytotoxic potency of novel tris(1-alkylindol-3-yl)methylium salts: role of N-alkyl substituents. Bioorg Med Chem 2010; 18: 18: 6905-6913.
20. Степанова E.B., Штиль A.A., Лавренов С.Н. и др. Соли трис(1-алки-линдол-3-ил)метилия - новый класс противоопухолевых соединений. Известия Академии наук. Сер химическая. 2010; 12: 1-9. / Stepanova E.V., Shtil' A.A., Lavrenov S.N. i dr. Soli tris(1-alkilindol-3-il)metilija - novyj klass protivoopukholevykh soedinenij. Izvestija Akademii nauk. Ser khimicheskaja. 2010; 12: 1-9. [in Russian]
21. Тренин А.С. Микробная модель Halobacterium salinarum для поиска ингибиторов биосинтеза стеролов. Антибиотики и химиотер 2013; 58: 5-6: 3-10.
22. Рекомендации Национального Комитета Клинических Лабораторных Стандартов США (NCCLS), [NCCLS Reference Method for Broth Dilution Antibacterial Susceptibility Testing, USA 2000]
23. Руководство по проведению доклинических исследований лекарственных средств. Часть 1. / Под ред. А.Н. Миронова. М.: Гриф и К, 2012; 944
24. Clinical and laboratory standards institute: Reference method for broth dilution antifungal susceptibility testing of yeasts. In Third International Supplement CLSI M27-S3. Clinical and Laboratory Standards Institute. Pensylvania. 2013.
25. Clinical and laboratory standards institute: Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. In approved standart. 2nd ed CLSI M38-A2. Clinical and Laboratory Standards Institute. Pensylvania. 2008.
26. Тренин А.С., Цвигун E.A., Бычкова О.П., Лавренов С.Н. Микробная модель Halobacterium salinarum в отборе синтетических аналогов антибиотика турбомицина А, обладающих противоопухолевым действием. Антибиотики и химиотер 2013; 58: 9-10: 3-7
27. Wayne P.A. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; Approved Standard. NCCLS Document M38-A. NCCLS. 2002. ISBN 1-56238-470-8
Рецензия
Для цитирования:
Лакатош С.А., Тренин А.С., Симонов А.Ю., Лавренов С.Н., Бычкова О.П., Цвигун Е.А. Новые биологически активные соединения в ряду производных 3-(индол-1-ил)-, З-(N-аминоарил)- и 3-(S-тиоарил)малеимида. Антибиотики и Химиотерапия. 2017;62(5-6):3-11.
For citation:
Lakatosh S.A., Trenin A.S., Simonov A.Yu., Lavrenov S.N., Bychkova O.P., Tsvigun E.A. New Biologically Active Compounds in the Series of 3-(indol-1-yl)-, 3-(N-aminoaryl)-, and 3-(S-thioaryl)Maleimide Derivatives. Antibiot Khimioter = Antibiotics and Chemotherapy. 2017;62(5-6):3-11. (In Russ.)